Delivery Order SPE2DB24D2101-SPE2DB25FKLHY

Award Date 6/11/25
Potential Completion Date 7/3/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FOTIVDA 1.34 MG CAPSULE 21S. The contract has a firm fixed price of $31,907.08 and a completion date of June 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication FOTIVDA 0.89 MG CAPSULE 21S, with a ceiling value of $32,270.40 and a period of performance through May 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The contract, valued at $15,420.59, is for the delivery of FOTIVDA 1.34 MG CAPSULE 21S pharmaceutical products to Conshohocken, Pennsylvania. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FOTIVDA 0.89 MG CAPSULE 21S. The contract has a ceiling value of $31,192.36 and an ultimate completion date of November 5, 2024. It is a firm-fixed-price contract type. This award is not associated with any set-aside program. AmerisourceBergen, through its Corporate Office Division, has been awarded numerous federal contracts and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit organization, to provide FOTIVDA 1.34 MG CAPSULE 21S, a pharmaceutical product, with a potential value of $30,841.18. The contract has a completion date of February 16, 2024 and was awarded on January 26, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is the prime contractor and is not operating under any set-aside designation. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $16,326.35 firm fixed-price delivery order is for the supply of the prescription drug FOTIVDA 0.89 MG CAPSULE 21S. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRODELVY 180 MG VIALS. The contract has a firm fixed price of $9,584.58 and a completion date of May 12, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
The Defense Logistics Agency awarded a delivery order valued at $15,596.18 to Amerisourcebergen Drug Corporation for the supply of 21 capsules of Fotivda, an oncology drug used to treat renal cell carcinoma. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania within the period of performance of June 27, 2023 through July 19, 2023. The firm fixed price contract was awarded utilizing Amerisourcebergen's position on an...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,779.44 firm fixed-price contract is for the supply of TRODELVY 180 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 4, 2025 and was awarded on February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,160.63 delivery order is for the supply of DOVATO 50-300 MG TABLET 30S, a medication, with a completion date of January 22, 2025. The overall IDC with DLA Troop Support Medical, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKLHY
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FOTIVDA 0.89 MG CAPSULE 21S. The contract has a firm fixed price of $16,135.20 and a period of performance extending to July 3, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/10/25, 10:05 AM